About this trial
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
Eligibility criteria
Qualifiers
60+ years old (adult)
English language fluency
owning a smartphone or tablet
Disqualifiers
Under 60 years old (minor)
Trial design
Treatments tested in this trial
- MediTrain
- Worder
Treatment groups
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
National Institute on Aging (NIA)
Collaborator